title: Topical cyclosporine prevents seasonal recurrences of vernal keratoconjunctivitis in a randomized, double-masked, controlled 2-year study.
authors.forename: Alessandro
authors.initials: A
authors.lastname: Lambiase
authors.forename: Andrea
authors.initials: A
authors.lastname: Leonardi
authors.forename: Marta
authors.initials: M
authors.lastname: Sacchetti
authors.forename: Velika
authors.initials: V
authors.lastname: Deligianni
authors.forename: Sabrina
authors.initials: S
authors.lastname: Sposato
authors.forename: Stefano
authors.initials: S
authors.lastname: Bonini
mesh_terms: D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D002648:Child; D003233:Conjunctivitis, Allergic / Q000276:immunology / Q000473:pathology / Q000517:prevention & control*; D016572:Cyclosporine / Q000008:administration & dosage* / Q000009:adverse effects; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D008297:Male; D012008:Recurrence; D013997:Time Factors
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine